Dyne Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dyne Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Dyne Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $25.6M, a 13.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $25.6M -$3.97M -13.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $26.6M -$3.95M -12.9% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $27.6M -$3.9M -12.4% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $28.6M -$3.86M -11.9% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $29.6M -$3.8M -11.4% Sep 30, 2023 10-Q 2023-10-30
Q2 2023 $30.6M -$3.73M -10.9% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $31.5M -$3.84M -10.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $32.5M -$3.82M -10.5% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $33.4M -$3.54M -9.59% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $34.3M +$33.9M +9021% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $35.4M +$34.8M +6195% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 $36.3M +$36.3M Dec 31, 2021 10-K 2023-03-02
Q3 2021 $36.9M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $376K Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $562K Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.